Back to calendar
BridgeBio Pharma, Inc. (BBIO) Earnings
BBIO reports earnings on Monday, August 3, 2026
earnings report
August 3, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.57
Actual EPS: $-0.84
EPS surprise: -23.75%
Company overview
Market Cap$15.7B
PriceUSD 79.96
EPS (TTM)-3.75
52-week high93.42
52-week low42.09
SectorHealth Technology
IndustryBiotechnology
Employees839